Excerpted from BMJ, Liming Lu, Yuqing Zhang, Gordon Guyatt, Chunzhi Tang, Nenggui Xu write: China has the potential to become one of the world’s most favoured sites for performing clinical trials.[1] Since 2008,[1] although China has seen a decline in the growth...
“There are a lot of new ways that we can use real world evidence to help inform regulatory decisions around medical products as the collection of this data gets more widespread and reliable. Better capture of real world data, collected from a variety of sources, has...
Excerpted from PMLive.com, There is increasing interest in digital trials, that is the use of mHealth and mobile technology to capture insights outside the traditional clinical setting. The drivers are clear – spiralling costs, questions with respect to existing...
Heidi Ledford for Nature writes (excerpt): “As companies increasingly focus on rare diseases and precision medicine tailored to a specific subset of patients, it has become more difficult to find willing volunteers who meet the necessary criteria. Recruitment...
New centers give study near complete coverage of North American FPC sites in drive to validate IMMrayTM PanCan-d, the first blood based test for early detection of pancreatic cancer Immunovia AB today announced that four additional North American Familial Pancreatic...
Email
Text